NASDAQ
CTT Pharmaceutical Holdings, Inc. (CTTH) has a price/fcf ratio of -45.85x as of Tuesday, May 26, 2026. This represents a 10.63% decrease compared to its 12-month average of -41.44x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.